Which is Better for Weight Loss: Semaglutide or Mounjaro?

Last reviewed: June 6, 2026

Last updated: June 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Both semaglutide and tirzepatide represent breakthrough medications for weight loss, yet they work through different biological mechanisms. Tirzepatide activates two hormone receptors—GLP-1 and GIP—while semaglutide targets GLP-1 alone, resulting in distinct efficacy profiles that may influence your treatment choice.

How Semaglutide and Tirzepatide Work Differently

Semaglutide is a GLP-1 receptor agonist that slows stomach emptying, reduces hunger signals in the brain, and improves blood sugar control. It has been used safely for diabetes management for years before gaining prominence in weight management. The medication works by mimicking glucagon-like peptide-1, a natural hormone that regulates appetite and satiety.

Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates two separate hormone pathways simultaneously. This dual action targets glucose metabolism through the GLP-1 pathway while also engaging the glucose-dependent insulinotropic polypeptide pathway. The combination of two mechanisms creates a more comprehensive metabolic effect than single-pathway therapy alone.

Weight Loss Efficacy: Clinical Trial Data Comparison

Semaglutide demonstrated average weight loss of 10-15% of body weight in major clinical trials over 68 weeks at the highest approved dosing. Results vary based on individual metabolism, adherence, and lifestyle factors. Many patients experience meaningful improvement in weight-related health conditions like blood pressure and cholesterol during treatment.

Tirzepatide showed greater average weight loss of 20-22% of body weight in clinical trials at the highest dose over similar timeframes. The dual-receptor mechanism enabled more pronounced appetite suppression and metabolic enhancement compared to semaglutide alone. These outcomes reflect tirzepatide's ability to influence multiple pathways involved in weight regulation and energy expenditure.

Side Effects and Tolerability Profile

Both medications share common gastrointestinal side effects including nausea, vomiting, diarrhea, and constipation, particularly during the initial weeks or dose escalation phases. These effects typically diminish over time as the body adapts to treatment. Staying hydrated and eating smaller, lower-fat meals can help minimize digestive discomfort during early treatment.

Tirzepatide may cause slightly higher rates of gastrointestinal side effects in some patients due to its dual-receptor activation, though serious adverse events remain rare in clinical populations. Both medications carry a black-box warning related to thyroid effects in animal studies, though no human cases of thyroid cancer have been confirmed. Individual tolerance varies significantly, and some patients experience minimal side effects while others benefit from gradual dose adjustment.

Choosing Between Semaglutide and Tirzepatide for Your Goals

Your choice between these medications depends on weight loss targets, tolerance for dual-mechanism therapy, cost considerations, and underlying metabolic factors. Patients seeking maximum weight loss efficacy and willing to tolerate potential gastrointestinal effects often benefit from tirzepatide's stronger dual action. Those prioritizing a gentler introduction or with a history of medication sensitivity may find semaglutide's single-pathway approach more suitable.

PlexusDx offers both semaglutide and tirzepatide formulations—injectable and oral—without requiring insurance or membership fees. The Precision Peptide Genetic Test identifies your genetic predispositions across 14 metabolic pathways, including variants in GLP1R, GIPR, FTO, and MC4R genes that influence your response to each medication class. This personalized insight helps guide whether a single GLP-1 approach or dual GIP/GLP-1 therapy aligns best with your genetic profile and weight loss objectives.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is tirzepatide more effective than semaglutide for weight loss?

Clinical trials show tirzepatide produces greater average weight loss (20-22%) compared to semaglutide (10-15%) at highest doses. Tirzepatide's dual GIP/GLP-1 mechanism enhances appetite suppression and metabolic effects beyond single-pathway therapy. However, individual results vary based on genetics, lifestyle, and adherence.

What is the difference between GLP-1 and GIP/GLP-1 receptor activation?

GLP-1 works through one pathway to slow digestion and reduce appetite. GIP/GLP-1 (tirzepatide) activates both pathways, amplifying insulin secretion, appetite suppression, and energy expenditure. The dual action typically produces stronger metabolic effects and greater weight reduction.

How much does tirzepatide cost through PlexusDx?

PlexusDx Tirzepatide Injection starts at $249/month and remains flat regardless of dose level—your dose may need to go up, but your price won't. No insurance is required, and injections are HSA/FSA eligible.

Are compounded semaglutide and tirzepatide safe?

PlexusDx sources all medications from licensed 503A compounding pharmacies, which operate under strict FDA oversight and state board regulations. Compounded medications are held to pharmaceutical-grade standards for purity and sterility. Both semaglutide and tirzepatide have established safety profiles from decades of clinical use.

Can genetic testing help me choose between semaglutide and tirzepatide?

PlexusDx Precision Peptide Genetic Test ($99 add-on) analyzes 150+ genetic insights across 14 pathways, including GLP1R and GIPR variants that influence medication response. These results help identify whether your genetics favor single or dual-receptor therapy for optimal weight loss outcomes.

Related Reading

• Semaglutide For Weight Loss 2
• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.